期刊文献+

帕利哌酮与奥氮平治疗精神分裂症的效果比较

A comparative study of paliperidone and olanzapine in the treatment of schizophrenia
原文传递
导出
摘要 目的探讨帕利哌酮与奥氮平治疗精神分裂症的效果。方法选取南京医科大学无锡精神卫生中心2018年1月至2019年6月收治的精神分裂症患者100例为研究对象,根据治疗方法分成帕利哌酮组和奥氮平组,每组50例。对比两组的治疗效果。结果治疗6周后,两组的治疗有效率比较差异未见统计学意义(P>0.05),且不良反应发生率比较,差异未见统计学意义(P>0.05)。治疗2周、4周后帕利哌酮组的阳性与阴性症状量表(PANSS)、阳性症状评分、阴性症状评分和一般病理评分均低于奥氮平组,差异有统计学意义(P<0.05)。治疗6周后的PANSS评分比较,组间差异未见统计学意义(P>0.05)。治疗6周后帕利哌酮组的社会功能量表(PSP)评分[(71.7±3.8)分]高于奥氮平组[(62.1±3.5)分],差异有统计学意义(P<0.05)。结论帕利哌酮和奥氮平治疗精神分裂症的疗效相当,不良反应发生率无差异,但帕利哌酮的见效快,且利于患者社会功能改善,值得推广。 Objective To investigate the effects of paliperidone and olanzapine on schizophrenia.Methods One hundred patients with schizophrenia admitted to Wuxi Mental Health Center Affiliated to Nanjing Medical University from January 20 to June 2019 were enrolled.The patients were divided into the paliperidone group and the olanzapine group according to the treatment method,with 50 cases in each group.The therapeutic effects of the two groups were compared.Results After 6 weeks of treatment,there was no significant difference in the effective rate between the two groups,and there was no significant difference in the incidence of adverse reactions(P>0.05).The PANSS score,positive symptom score,negative symptom score and general pathological score after 2 weeks and 4 weeks of treatment were lower in paliperidone group than those in olanzapine group(P<0.05).The PANSS scores after 6 weeks of treatment were not significantly different between the groups(P>0.05).The PSP scores after 6 weeks of treatment were higher in the paliperidone group[(71.7±3.8)scores]than those in the olanzapine group[(62.1±3.5)scores],the difference was significant(P<0.05).Conclusions Palipe ridone and olanzapine have similar efficacy and few adverse reactions in the treatment of schizophrenia,but paliperidone has quick effect and is beneficial to the improvement of social function of patients,which is worthy of promotion.
作者 周勤 Zhou Qin(Department of Pharmacy,Wuxi Mental Health Center Affiliated to Nanjing Medical University,Wuxi 214151,China)
出处 《临床医学》 CAS 2020年第5期86-88,共3页 Clinical Medicine
关键词 帕利哌酮 奥氮平 精神分裂症 社会功能 PANSS评分 不良反应 Paliperidone Olanzapine Schizophrenia Social function PANSS score Adverse reactions
  • 相关文献

参考文献10

二级参考文献79

  • 1潘能荣,黄自勇,李哲.棕榈酸帕利哌酮注射液治疗急性精神分裂症的疗效及安全性研究[J].医学信息(医学与计算机应用),2014,0(30):87-87. 被引量:3
  • 2苏芬丽,周志凌,李焕德.HPLC-MS法检测利培酮与9-羟利培酮的血浆浓度及在临床药动学的应用[J].药物分析杂志,2006,26(2):207-211. 被引量:8
  • 3Kane JM. Pharmacologic treatment of schizophrenia [ J ]. Biol Psychiatry, 1999,46 : 1396 - 1408. 被引量:1
  • 4Gonzdlez - Rodrlguez A, Cataldn R, Penad~s R, et al. Profile of paliperidone palmitate once - monthly long - acting injectable in the management of schizophrenia : Long - term safety, efficacy, and patient acceptability - a review [ J ]. Patient Prefer Adherence, 2015,25:695 -706. 被引量:1
  • 5Samtani MN, Gopal S, Gassmann - Mayer C, et al. Dosing and switching strategies for Paliperidone palmitate:Based on popula- tion pharmacokinetic modelling and clinical trial data [ J ]. CNS Drugs ,2011,25:829 - 845. 被引量:1
  • 6Bossie CA, Sliwa JK, Ma YW, et al. Onset of efficacy and tolera- bility following the initiation dosing of long - acting Paliperidone palmitate : Post - hoc analyses of a randomized, double - blind clinical trial[ J]. BMC Psychiatry ,2011,10:79 - 81. 被引量:1
  • 7Pandina G, Lane R, Gopal S, et aL A double - blind study of Pali- peridone palmitate and risperidone long- acting injectable in adults with schizophrenia [ J 1. Prog Neuropsychopharmacol Biol Psychiatry ,2011,35:218 - 226. 被引量:1
  • 8Coppola D,Liu Y,Gopal S,et al. A one -year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of Paliperidone palmitate in patients with schizo- phrenia[J]. BMC Psychiatry ,2012,28 : 12 - 26. 被引量:1
  • 9Bossie CA, Fu D J, Sliwa JK, et al. Tolerability of initiation doses of once - monthly Paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial [ J ]. Ther Adv Psychopharmaco1,2011,1 : 111 - 124. 被引量:1
  • 10Alphs L, Bossie CA, Sliwa JK, et al. Onset of efficacy with acute long - acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: Post hoc analysis of a randomized, double - blind clinical trial[J].Ann Gen Psychiatry ,2011,10 : 12 - 14. 被引量:1

共引文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部